Home  |  Browse  |  Authors  |  Advanced Search  |  Help
Login | Create Account
Cremer, Thomas; Zorn, Christian; Cremer, Christoph and Zimmer, J. (1976): Formation of viable cell fragments by treatment with colchicine. In: Experimental Cell Research, Vol. 100: pp. 345-355.

Metadaten exportieren

Autor(en) recherchieren

Lesezeichen anlegen

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Reader
4Mb
DOI: http://dx.doi.org/10.1016/0014-4827(76)90158-0

Abstract

Time-lapse cinematography of human fibroblasts revealed that mitotic cells separated into numerous cell fragments containing varying amounts of chromatin and cytoplasm when treated with colchicine. As cell fragments were very loosely attached to the surface of the culture vessel during their formation, they could be easily detached like mitotic cells by gently shaking the vessel and thus separated from normal interphase cells. Fragments obtained by this procedure were able to exclude trypan blue indicating, therefore, an intact cell membrane. When placed into Petri dishes many of them attached to and even spread out on the surface. Five hours later the majority of the attached fragments incorporated [3H]leucine. Time-lapse films showed that fragments were able to extend and retract pseudopodia at least for several hours after their formation. Although the fragments degenerated within a few days, in the present experiments the possibility was not excluded that fragments which had lost only a very small amount of chromatin and cytoplasm survived for longer periods of time. The observations clearly indicate viability of many newly formed fragments.

Item Type:Article
Subjects:Medicine
Dewey Classification:600 Technology, Medicine
600 Technology, Medicine > 610 Medical sciences and medicine
URN:urn:nbn:de:bvb:19-epub-7559-4
ID Code:7559
Deposited On:18. Nov 2008 14:55
Last Modified:28. Jun 2010 15:11
Open Access LMU is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software creditsAbout